Mechanism

EGFR C797S (also active on T790M)

Assets acting on this target.

Class
Fourth-generation EGFR tyrosine kinase inhibitor (oral)
Pathway
EGFR signaling; overcomes C797S/T790M steric-hindrance resistance mechanisms
Research

Explore this mechanism at different depths

Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.

Company

0 of 0 assets

No assets match these filters.

← all assets